Literature DB >> 27184659

Dityrosine as a marker of acute myocardial infarction? Experiments with the isolated Langendorff heart.

F Mayer1, M Falk2, R Huhn3, F Behmenburg3, S Ritz-Timme2.   

Abstract

The isolated Langendorff heart was used to evaluate dityrosine as a marker of acute myocardial infarctions. The animal model allowed the generation of local infarctions with defined survival times, as well as infarctions with and without reperfusion. The results showed that dityrosine, at least under the conditions of the animal model, occurs very shortly after early ischemia and infarctions, since positive staining results were already obtained after a survival time of only 5 min. Furthermore, it could be proved that the occurrence of dityrosine does not depend on a reperfusion of the ischemic muscle area and that there are no differences in the staining patterns of infarctions with and without reperfusion. Positive staining results for dityrosine in control hearts without infarctions had to be considered when evaluating the tissue samples of the study hearts. In part, the positive staining results of the control hearts seemed to be an artefact of the Langendorff system, easily identifiable by a distinctive staining pattern. Positive staining results in tissue samples of hearts that suffered from arrhythmia on the other hand implied that the occurrence of dityrosine is not specific for myocardial infarctions. Taking into account the results of previous works on human tissue samples, however, these findings did not question the use of dityrosine as a diagnostic tool; they simply showed that myocardial damage due to oxidative stress might occur under various pathologic conditions.

Entities:  

Keywords:  Animal model; Immunohistochemistry; Myocardial infarction; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27184659     DOI: 10.1007/s00414-016-1376-6

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  20 in total

1.  A comparative study on the immunohistochemical detection of early myocardial damage.

Authors:  C Ortmann; H Pfeiffer; B Brinkmann
Journal:  Int J Legal Med       Date:  2000       Impact factor: 2.686

2.  Experimental myocardial infarction. I. A method of coronary occlusion in small animals.

Authors:  T N P JOHNS; B J OLSON
Journal:  Ann Surg       Date:  1954-11       Impact factor: 12.969

Review 3.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.

Authors:  E J Lesnefsky; S Moghaddas; B Tandler; J Kerner; C L Hoppel
Journal:  J Mol Cell Cardiol       Date:  2001-06       Impact factor: 5.000

4.  Immunohistochemical study of fibronectin in experimental myocardial infarction.

Authors:  W Casscells; H Kimura; J A Sanchez; Z X Yu; V J Ferrans
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

5.  What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat?

Authors:  E R Schwarz; Y Somoano; S L Hale; R A Kloner
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

6.  Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species.

Authors:  Maria-Giulia Perrelli; Pasquale Pagliaro; Claudia Penna
Journal:  World J Cardiol       Date:  2011-06-26

7.  The isolated perfused rat heart: a model for studying myocardial hypoxia or ischaemia.

Authors:  J de Leiris; D P Harding; S Pestre
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

8.  The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage.

Authors:  B Brinkmann; M A Sepulchre; G Fechner
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686

9.  One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model.

Authors:  R Ferrera; S Benhabbouche; J C Bopassa; B Li; M Ovize
Journal:  Cardiovasc Drugs Ther       Date:  2009-08       Impact factor: 3.727

10.  Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction.

Authors:  Haitao Bi; Ying Yang; Jianye Huang; Yingmin Li; Chunling Ma; Bin Cong
Journal:  Diagn Pathol       Date:  2013-05-17       Impact factor: 2.644

View more
  3 in total

1.  The impact of sex and myocardial ischemic preconditioning on immunohistochemical markers of acute myocardial infarction.

Authors:  K Scholl; R Huhn; St Ritz-Timme; F Mayer
Journal:  Int J Legal Med       Date:  2018-10-23       Impact factor: 2.686

2.  Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers?

Authors:  M Falk; R Huhn; F Behmenburg; St Ritz-Timme; F Mayer
Journal:  Int J Legal Med       Date:  2017-11-18       Impact factor: 2.686

3.  Reversible Oxidative Modifications in Myoglobin and Functional Implications.

Authors:  Mark H Mannino; Rishi S Patel; Amanda M Eccardt; Blythe E Janowiak; David C Wood; Fahu He; Jonathan S Fisher
Journal:  Antioxidants (Basel)       Date:  2020-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.